Published in Medicine and Law Weekly, October 29th, 2004
Currently under development, Amedica's new spine grafts covered under this and pending patents will be used as a bio-safe alternative to autograft bone, taken directly from the patient, or allograft bone, taken from viable donors.
Due to the breadth and versatility of the patented technology, the company expects surgeons to easily apply it in virtually any type of bone defect site.
"The range of products that this patent and other pending patents allow represents a significant portion of our spine and orthobiologics product...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.